Breast Cancer Risk Reduction: A Patient Doctor Intervention

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

Key facts

Study ID

NCT01830933

Run by

University of California, San Francisco

People needed

1235

Starts

2011-06-01

Expected to finish

2012-12-01

Last updated by the study team

2014-08-19

Who can join

Age: 40 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient component:
• Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
• Between the ages of 40 and 74
• Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
• Have no history of breast cancer are eligible to participate.
• Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF

You may not qualify if…

• Patient component: Women whose physicians object to their participation in the study
• Physician component: No exclusion criteria for physicians

Where it is running

• San Francisco General Hospital (SFGH) — San Francisco, California, United States
• University of California, San Francisco Mt. Zion campus — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.